Special Reports & Webinars

SR&W Circle 1
SR&W Circle 2
Special Reports & Webinars Icon

About Special Reports & Webinars

HIRC Special Reports & Webinars are designed to keep pharmaceutical professionals informed on emerging market developments in real-time. As a supplement to HIRC’s syndicated research services, the series consists of releases throughout the year either in live/archived webinar or special report format, covering the latest trends and special interest topics. Access is based on your company’s current subscription. These resources are also available for purchase.

Go Deeper on Webinars

Stay Connected

Subscribers:
Register/Login

Sign up for new
research alerts

Join a research
panel

Research Updates

2026 Research

Special Report: The Contracting Environment in 2026

July 2026. Examines the current market trends impacting the contracting environment and reviews contract prevalence with commercial payers. Examines most common contracting approaches and rebate/discount amounts offered across 40+ therapeutic areas spanning traditional, specialty and oncology. Alternative contracting is also explored (e.g., portfolio, outcomes-based, and indication-based).

Special Report: The Contracting Environment in 2026

Pharmaceutical manufacturer contracting is a key element of account engagement to enhance and/or maintain market access; however, the contracting landscape can vary greatly by therapeutic…Learn More
No results found.

Webinar Series

Webinar Slides & Playback: 2026 Market Access: What’s Sticking, What’s Shifting, and What’s Waning, May 2026

Key learnings include the latest PBM and policy developments, such as the ESI/FTC settlement, evolving pricing models, such as IRA Maximum Fair Prices, Most Favored Nations pricing, and direct-to-patient programs, payer management trends spanning biosimilars, medical management, & copay adjustment programs, and what these trends mean for contracting and engagement strategies for 2026 success.

Holidays with HIRC: Unwrapping What’s Next in Pharma Market Access, December 2025

Key learnings include: The latest IRA developments and other policy updates, including the OBBBA, MFN pricing, and ACIP disruptions, Emerging pricing and rebate models, including TrumpRx, direct-to-patient, and Cigna’s new rebate model, Payer management trends in oncology, biosimilars, and rare disease from HIRC 2025 research, and Contracting and engagement strategies for 2026 success.

People’s Choice Market Access Trends Webinar, April 2025

Key learnings include: Inflation Reduction Act Updates, Update on PBM-owned GPOs, including Synergie, 340B Developments, Biosimilars Update, including Private-Label Trends Payer Management Trends, Rare Disease Focus, and Highlights from HIRC’s Latest 2025 Account Engagement & Contracting Data to Support Market Access Strategies

Illuminating the Latest Industry Trends and their Impact on Market Access: The IRA & Beyond, October 2024

Key learnings include: Key Payer & Provider Market Updates, Inflation Reduction Act – Changes to Part D Benefit Design & Payer Responses, Inflation Reduction Act – Negotiated Drug Prices & Payer Responses, Latest Trends in Payer Medication Management, with an added focus in Oncology, and Maintaining Market Access with Effective Account Engagement & Contracting
No results found.

Go Deeper:
Webinar Series

The webinar schedule and topics vary based upon to the current health care environment. Research directors and consultants select topics or new data/insights that they feel are critical for manufacturers to be aware of.

Please contact us if you have a particular topic of interest for us to consider for our next webinar. HIRC full-service clients may access full webinar presentation materials and on demand recordings at any time.

Karen Ernst has decades of experience in the health care and pharmaceutical industries, including nearly two decades of conducting research and analysis across HIRC services and providing strategic consulting insights to clients.

Lisa Nanfra has 20+ years experience in the biopharma space as commercial executive leading sales, national account and marketing teams responsible for blockbuster brands. Lisa’s diverse experience has equipped her with a deep understanding of the macro healthcare environment and the challenges within it.